| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Inès M Bigarré, Bianca A Trombetta, Yan-Jun Guo, Steven E Arnold, Becky C Carlyl. IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology. Brain and behavior. vol 11. issue 4. 2021-06-30. PMID:33704916. |
to identify circular rnas as candidates for differential expression in the middle temporal (mt) cortex in a well-characterized cohort with contrasting alzheimer disease (ad) pathology and cognition. |
2021-06-30 |
2023-08-13 |
Not clear |
| Ya-Juan Wang, Yu Wan, Hui-Fu Wang, Chen-Chen Tan, Jie-Qiong Li, Jin-Tai Yu, Lan Ta. Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders. Journal of Alzheimer's disease : JAD. vol 68. issue 2. 2020-07-22. PMID:30883353. |
our study examined the effects of the two ad-related cd33 common variants (rs3826656 and rs3865444) on the chosen ad-related brain regions (including hippocampus, amygdala, parahippocampus, middle temporal, entorhinal cortex, and total brain volume) in non-demented elders recruited from the alzheimer's disease neuroimaging initiative database at baseline and during four-year follow-up. |
2020-07-22 |
2023-08-13 |
Not clear |
| Jia-Hao Sun, Hui-Fu Wang, Xi-Chen Zhu, Wan-Jiang Yu, Chen-Chen Tan, Teng Jiang, Meng-Shan Tan, Lan Tan, Jin-Tai Y. The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease. Molecular neurobiology. vol 53. issue 10. 2017-12-29. PMID:26660111. |
in 812 subjects from the alzheimer's disease neuroimaging initiative (adni) dataset, we explored the genotypes of unc5c loci in the volumes of the hippocampus, parahippocampal gyrus, posterior cingulate gyrus, middle temporal and precuneus, and the thickness of the entorhinal cortex which are measured by magnetic resonance imaging (mri). |
2017-12-29 |
2023-08-13 |
human |
| Marc Teichmann, Aurélie Kas, Claire Boutet, Sophie Ferrieux, Marie Nogues, Dalila Samri, Christina Rogan, Didier Dormont, Bruno Dubois, Raffaella Migliacci. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain : a journal of neurology. vol 136. issue Pt 11. 2013-12-31. PMID:24108322. |
concordantly, logopenic aphasia due to probable alzheimer pathology demonstrated more extensive brain hypoperfusion involving larger regions throughout the inferior parietal, the posterior-superior and the middle temporal cortex. |
2013-12-31 |
2023-08-12 |
Not clear |
| Gwenn S Smith, Elisse Kramer, Yilong Ma, Carol R Hermann, Vijay Dhawan, Thomas Chaly, David Eidelber. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain : a journal of neurology. vol 132. issue Pt 2. 2009-03-10. PMID:19153152. |
at baseline, cerebral glucose metabolism was reduced in alzheimer's disease patients relative to controls in right middle temporal, left posterior cingulate and parietal cortices (precuneus and inferior parietal lobule), as expected. |
2009-03-10 |
2023-08-12 |
human |
| J A P van de Nes, R Nafe, W Schlot. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain research. vol 1213. 2008-09-19. PMID:18455153. |
non-tau based neuronal degeneration in alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. |
2008-09-19 |
2023-08-12 |
human |
| M Y Aksenov, M V Aksenova, D A Butterfield, J W Geddes, W R Markesber. Protein oxidation in the brain in Alzheimer's disease. Neuroscience. vol 103. issue 2. 2001-06-14. PMID:11246152. |
increased protein oxidation was detected in sections from the hippocampus and parahippocampal gyrus, superior and middle temporal gyri of six alzheimer's disease and six age-matched control human subjects, but not in the cerebellum. |
2001-06-14 |
2023-08-12 |
human |
| A Convit, J de Asis, M J de Leon, C Y Tarshish, S De Santi, H Rusine. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiology of aging. vol 21. issue 1. 2000-07-07. PMID:10794844. |
atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to alzheimer's disease. |
2000-07-07 |
2023-08-12 |
Not clear |
| Q Hu, L W Jin, M Y Starbuck, G M Marti. Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. Journal of neuroscience research. vol 60. issue 1. 2000-04-12. PMID:10723070. |
we quantitated the two isoforms in middle temporal cortex, middle frontal cortex, cerebellar cortex and caudate nucleus of 17 alzheimer disease (ad) patients, 12 normal controls and 9 non-ad neurodegenerative disease controls by reverse transcription-competitive polymerase chain reaction (rt-cpcr). |
2000-04-12 |
2023-08-12 |
human |
| M A Deibel, W D Ehmann, W R Markesber. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981312. |
copper (cu), iron (fe), and zinc (zn) levels in five different brain regions (amygdala, hippocampus, inferior parietal lobule, superior and middle temporal gyri, and cerebellum) were determined by instrumental neutron activation analysis (inaa) in samples from alzheimer's disease (ad) patients and age-matched control subjects. |
1997-03-20 |
2023-08-12 |
human |
| M A Lovell, W D Ehmann, S M Butler, W R Markesber. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. vol 45. issue 8. 1995-09-20. PMID:7644059. |
we determined levels of thiobarbituric acid-reactive substances (tbars), a measure of lipid peroxidation, and the activity of the antioxidant enzymes superoxide dismutase (sod), glutathione peroxidase (gsh-px), glutathione reductase (gssg-r), and catalase (cat) in the amygdala, hippocampus, pyriform cortex, superior and middle temporal gyri, inferior parietal lobule, middle frontal gyrus, occipital pole, and cerebellum of 13 alzheimer's disease (ad) and 10 control brains. |
1995-09-20 |
2023-08-12 |
human |
| K Chandrasekaran, T Giordano, D R Brady, J Stoll, L J Martin, S I Rapopor. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain research. Molecular brain research. vol 24. issue 1-4. 1994-12-07. PMID:7968373. |
brains from 5 patients with alzheimer's disease (ad) showed a 50%-65% decrease in mrna levels of the mitochondrial-encoded cytochrome oxidase (cox, a marker of oxidative metabolism) subunits i and iii in the middle temporal association neocortex, but not in the primary motor cortex, as compared to 5 control brains. |
1994-12-07 |
2023-08-12 |
Not clear |
| C Whitford, J Candy, J Edwardson, R Perr. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases. Journal of the neurological sciences. vol 86. issue 1. 1988-11-04. PMID:2902199. |
in the present study, the levels of both sli and high affinity [3h]somatostatin binding sites have been measured in the frontal (brodmann area 9) and temporal (brodmann area 21) cortices in patients with presenile and senile alzheimer's disease, and in mentally normal and cognitively impaired cases of parkinson's disease. |
1988-11-04 |
2023-08-11 |
Not clear |
| D Dawbarn, M N Rossor, C Q Mountjoy, M Roth, P C Emso. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type. Neuroscience letters. vol 70. issue 1. 1986-12-17. PMID:2877420. |
the content of srif-like immunoreactivity (srif-li) was found to be decreased in alzheimer temporal cortex (brodmann area 21) compared to control temporal cortex. |
1986-12-17 |
2023-08-11 |
Not clear |